InvestmentUpdated on 8 May 2026
ENDOless - The Future of Women’s Health Data & Research
CEO at ENDOless
Paris, France
About
ENDOless is an AI-powered women’s health platform focused on chronic pain and underdiagnosed conditions such as endometriosis.
We help women track symptoms and wearable data while transforming this information into structured real-world evidence for researchers, pharma, healthcare providers, and insurers.
Why ENDOless is a strong investment opportunity:
-
Massive underserved market with over 190M women affected by endometriosis alone
-
Strong macro trend in FemTech, AI healthcare, and real-world data
-
Multi-revenue model across B2C, B2B, and Research-as-a-Service
-
High-value proprietary datasets and scalable AI infrastructure
-
Early traction with beta users, ecosystem support, and institutional interest
-
Positioned at the intersection of digital health, AI, and women’s health research
ENDOless is building the infrastructure layer for the future of women’s chronic health.
Stage
- Seed funding | Get business started
Organisation
Paris, France
Similar opportunities
Product
Seeking Pilot Partners for Women’s Health AI Platform
- Investment/Finance
- Demonstration / Pilot projects
Alexandra Mont
CEO at ENDOless
Paris, France
Investment
Seed Investment: artinLeap – Scaling the Future of B2B AI Agent Orchestration
- Seed funding | Get business started
Pablo Fernández
CEO & Founder at ArtinLeap
Valbonne, France
Product
EU distribution partners — sport-wellness app, B2C and B2B2C
Emmanuel Cardi
Fondateur et Président — Founder & President at ALVIA SASU
Ajaccio, France